CM512 Injection

CM512 · Keymed Biosciences Co. Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CM512 Injection, covering 2025-08-28 to 2025-08-28. Get the full timeline:

Most recent: Clinical Trial Update: Study of CM512 Injection in Subjects With Moderate-to-severe Asthma [Phase 2]